These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 1960877)

  • 1. [Clinical trial of protease inhibitor in the treatment of fulminant hepatitis].
    Yasunaga M; Mori K; Yamashita S; Okita K
    Nihon Rinsho; 1991 Sep; 49(9):2120-4. PubMed ID: 1960877
    [No Abstract]   [Full Text] [Related]  

  • 2. [Treatment of disseminated intravascular coagulation with proteinase inhibitor].
    Okamoto K; Takeda S; Ohsato K
    Nihon Rinsho; 1991 Sep; 49(9):2130-5. PubMed ID: 1960878
    [No Abstract]   [Full Text] [Related]  

  • 3. [Syndrome of disseminated intravascular coagulation in diseases of the digestive organs].
    Shchepotin BM; Ena IaM
    Klin Med (Mosk); 1985 Mar; 63(3):23-30. PubMed ID: 3889490
    [No Abstract]   [Full Text] [Related]  

  • 4. Clinical evaluation of antithrombin III concentrate (BI 6.013) for disseminated intravascular coagulation in obstetrics. Well-controlled multicenter trial.
    Maki M; Terao T; Ikenoue T; Takemura T; Sekiba K; Shirakawa K; Soma H
    Gynecol Obstet Invest; 1987; 23(4):230-40. PubMed ID: 3111953
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Synthetic protease inhibitors for the treatment of DIC].
    Takahashi H
    Rinsho Byori; 2011 Feb; Suppl 147():152-8. PubMed ID: 21761764
    [No Abstract]   [Full Text] [Related]  

  • 6. [Current views on the therapeutic use of heparin and antithrombin III in disseminated intravascular coagulation].
    Sobczyk J; Swietliński J; Podleśny-Owsińska T
    Pol Tyg Lek; 1989 Oct 2-16; 44(40-42):896-8. PubMed ID: 2487947
    [No Abstract]   [Full Text] [Related]  

  • 7. [Protease inhibitors in shock].
    Motoki R; Inoue H
    Nihon Rinsho; 1991 Sep; 49(9):2090-4. PubMed ID: 1720471
    [No Abstract]   [Full Text] [Related]  

  • 8. [Antithrombin III in the treatment of disseminated intravascular coagulation].
    Nordgaard-Andersen I; Madsen JR
    Ugeskr Laeger; 1997 Feb; 159(6):730-1. PubMed ID: 9045459
    [No Abstract]   [Full Text] [Related]  

  • 9. [Synthetic protease inhibitors in the treatment of disseminated intravascular coagulation].
    Aramoto H; Saito H; Shigematsu H; Muto T
    Nihon Rinsho; 1993 Jan; 51(1):93-8. PubMed ID: 8433532
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Principles of the therapy for disseminated intravascular coagulation: current status and new trends].
    Takahashi H
    Nihon Rinsho; 1993 Jan; 51(1):79-86. PubMed ID: 7679452
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effective use of camostat mesilate for chronic disseminated intravascular coagulation complicated by thoracoabdominal aortic aneurysm].
    Yoneda K; Amano I; Tanaka H; Yagi H; Tsukaguchi N; Morii T; Narita N
    Rinsho Ketsueki; 2001 Jan; 42(1):30-4. PubMed ID: 11235131
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antithrombin III concentrates for treatment of disseminated intravascular coagulation in children.
    Hanada T; Abe T; Takita H
    Am J Pediatr Hematol Oncol; 1985; 7(1):3-8. PubMed ID: 4037242
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Is antithrombin III for sepsis-associated disseminated intravascular coagulation really ineffective?
    Iba T; Thachil J
    Intensive Care Med; 2016 Jul; 42(7):1193-4. PubMed ID: 27143022
    [No Abstract]   [Full Text] [Related]  

  • 14. Treatment of disseminated intravascular coagulation with gabexate mesilate.
    Tamaki S; Wada H; Hiyoyama K; Shimura M; Minamikawa K; Wakita Y; Nakase T; Ohiwa M; Kaneko T; Iwasaki E
    Clin Ther; 1993; 15(6):1076-84. PubMed ID: 8111805
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Therapy of disseminated intravascular coagulation].
    Matsuda T
    Rinsho Byori; 1985 Jun; Spec No 63():79-89. PubMed ID: 3930817
    [No Abstract]   [Full Text] [Related]  

  • 16. Therapeutic use of antithrombin III in shock and disseminated intravascular coagulation.
    Vinazzer H
    Semin Thromb Hemost; 1989 Jul; 15(3):347-52. PubMed ID: 2688106
    [No Abstract]   [Full Text] [Related]  

  • 17. [Effect of heparin and/or antithrombin III in a model of disseminated intravascular coagulation induced by endotoxin in rabbits].
    Gómez C; Páramo JA; Rocha E
    Sangre (Barc); 1992 Feb; 37(1):5-10. PubMed ID: 1585238
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Japanese consensus for disseminated intravascular coagulation (DIC): is it a small world after all?
    Levi M
    Thromb Res; 2010 Jan; 125(1):4-5. PubMed ID: 19735937
    [No Abstract]   [Full Text] [Related]  

  • 19. [Adequate parameters for the diagnosis of disseminated intravascular coagulation (DIC) in patients with liver diseases].
    Iwabuchi S; Takatori M; Okabe K
    Nihon Rinsho; 1993 Jan; 51(1):67-73. PubMed ID: 8381886
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The protease inhibitor treatment of the disseminated intravascular coagulation syndrome in patients with liver cirrhosis].
    Mateva L; Donkova O
    Vutr Boles; 1991; 30(2):105-10. PubMed ID: 1716395
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.